
Osteoconduction Determination of Mineral Coated Silicon Dioxide NanospringsAward last edited on: 00/00/00
Sponsored Program
SBIRAwarding Agency
NSFTotal Award Amount
$150,000Award Phase
1Solicitation Topic Code
-----Principal Investigator
Jamie HassCompany Information
MJ3 Industries
PO Box 105
Cataldo, ID 83810
Cataldo, ID 83810
(208) 600-7297 |
N/A |
N/A |
Location: Single
Congr. District: 01
County: Kootenai
Congr. District: 01
County: Kootenai
Phase I
Contract Number: ----------Start Date: ---- Completed: ----
Phase I year
2013Phase I Amount
$150,000The broader impact/commercial potential of this project to the osteoconductive biomaterial market is vast. The orthopedic market is a multi-billion dollar industry, which will increase as the baby boomer population ages. This technology can be employed in both animal and human devices, such as dental implants, prosthetics, and joint replacements. The potential commercialization options are partnering with an existing orthopedic device manufacturer for this add-on coating, or direct sales to the animal market, and then to the human market as the FDA allows. The coated nanosprings have the ability to greatly increase the rate and hardness of bone deposition. It is hypothesized that this increase around implants can have a significant clinical impact to improve the quality of patient?s lives as well as an economical benefit. This new technology can provide employment for scientists in both biologic and other hard science fields. The nanosprings are an ideal foundation for osteoconductive research. This synthetic collagen allows different coating material to be studied at a nanoscale level. Thus, providing both materials and biologic insight to the osseointegration process.
Phase II
Contract Number: ----------Start Date: ---- Completed: ----